ADE regimen

{
  "id": "MLC-T-ONC-000234",
  "term": "ADE regimen",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An abbreviation for a chemotherapy combination used to treat childhood acute myeloid leukemia (AML). It includes the drugs cytarabine (Ara-C), daunorubicin hydrochloride, and etoposide phosphate. Also called ADE.",
    "A regimen consisting of high-dose cytarabine (Ara-C), daunorubicin and etoposide, that is used for the treatment of pediatric and adult acute myeloid leukemia (AML)."
  ],
  "abbreviation": "ARA-C/DNR/VP-16",
  "synonyms": [
    "ADE",
    "cytarabine-daunorubicin-etoposide regimen",
    "AraC-daunorubicin-etoposide regimen",
    "cytarabine/daunorubicin/etoposide",
    "MRC AML10 study-ADE regimen",
    "high-dose cytarabine-daunorubicin-etoposide regimen",
    "high-dose cytarabine/daunorubicin/etoposide",
    "high-dose cytarabine/daunorubicin/etoposide regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/ade-regimen/"
}